🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.50
-0.30 (-0.42%)
Nov 20, 2026, 1:24 PM CST

WeLeader Biomedical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
122.97237.71174.9794.69100.73111.52
Short-Term Investments
-9734.377.838.44.18
Trading Asset Securities
30.17-2.832.432.333.01
Cash & Short-Term Investments
153.14334.71212.17104.95111.45118.71
Cash Growth
-48.72%57.76%102.16%-5.83%-6.11%-
Accounts Receivable
391.65322.51276.87273.63279.43290.68
Other Receivables
2.45--0.050.11.03
Receivables
394.1322.51276.87273.69279.52291.71
Inventory
123.66117.9399.0669.6762.7355.89
Other Current Assets
111.175.233.212.111.022.11
Total Current Assets
782.07780.39591.32450.42454.73468.42
Property, Plant & Equipment
1,1851,5891,3411,1941,086351.66
Long-Term Investments
12.3243.1326.8242.8727.8429.6
Other Intangible Assets
7.332.474.063.885.746.13
Long-Term Deferred Tax Assets
0.80.670.460.690.790.49
Other Long-Term Assets
647.6633.534.6336.0225.2426.8
Total Assets
2,6352,4491,9981,7281,600883.09

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
218.94214.45183.54143.19155.28160.65
Accrued Expenses
-68.956.8255.2748.1844.01
Short-Term Debt
--8057121.0353
Current Portion of Long-Term Debt
-1.0317.4416.9715.0213.63
Current Portion of Leases
120.1295.5281.4374.6249.7553.93
Current Income Taxes Payable
24.9731.0625.5423.8734.4623.84
Current Unearned Revenue
5.545.21.520.340.71.95
Other Current Liabilities
92.3316.1522.7130.4314.1312.81
Total Current Liabilities
461.9432.3469.01401.69438.54363.81
Long-Term Debt
480.83488.43397.96249.03270.2318.65
Long-Term Leases
428.9268.14219.94228.38245.22142.99
Long-Term Deferred Tax Liabilities
0.11----0
Other Long-Term Liabilities
2.76-2.692.690.20.22
Total Liabilities
1,3741,1891,090881.78954.19525.68

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
454.8454.79415.79415.79342.46193.49
Additional Paid-In Capital
384.46384.31141.13141.1392.968.73
Retained Earnings
426.86406.54351.16276.57213.89155.2
Comprehensive Income & Other
-5.814.490.3912.29-3.01-
Shareholders' Equity
1,2601,260908.47845.78646.3357.41
Total Liabilities & Equity
2,6352,4491,9981,7281,600883.09

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,030853.11796.77626701.25282.19
Net Cash (Debt)
-876.71-518.4-584.6-521.05-589.79-163.49
Net Cash Growth
------
Net Cash Per Share
-17.14-11.16-14.01-12.68-19.38-5.82
Filing Date Shares Outstanding
45.3945.4841.5841.5934.2527.88
Total Common Shares Outstanding
45.3945.4841.5841.5934.2527.88
Working Capital
320.17348.08122.3148.7316.19104.61
Book Value Per Share
27.7727.7121.8520.3418.8712.82
Tangible Book Value
1,2531,258904.41841.9640.56351.28
Tangible Book Value Per Share
27.6127.6521.7520.2418.7012.60
Land
-652.61652.61652.61657.234.62
Buildings
----11.9311.93
Machinery
-20.0119.4628.5325.9724.65
Construction In Progress
-519.58318.14144.957.430.38